Bulk Crap Uninstaller (or BCUninstaller) is an open-source tool that lets you bulk uninstall Microsoft Store apps as well as third-party programs from your computer. This tool lets you uninstall ...

BlueScreenView is a free crash dump analyzer software for Windows 11/10. It is used to analyze BSoD and minidump files. You can view minidump files using it and the reasons that caused your PC to ...

Anna Baluch is a freelance writer from Cleveland, Ohio. She enjoys writing about a variety of health and personal finance topics. When she's away from her laptop, she can be found working out ...

Husqvarna will expand its electric motorcycle lineup with the new Pioneer for 2025, essentially the Husqvarna version of the KTM Freeride. Like the Freeride, the Pioneer gets a 5.5 kWh Li-Ion battery ...

My go-to program is CRM (customer relationship management). Before you can dive into estimating, project management, procurement, scheduling or financial apps, you need to secure a signed contract.

Husqvarna announce all-new Pioneer electric-powered motorcycle to the enduro model range for 2025. “The perfect solution to recreational riding”? Husqvarna’s new electric motorcycle, the Pioneer, ...

Husqvarna has taken the covers off their new street-legal electric dirt bike, the Pioneer, running an MX50 5.5 kWh Li-Ion battery and offering up to 137 km of range (WMTC), or a run time of up to ...

Nov 4 (Reuters) - Viking Therapeutics (VKTX.O), opens new tab shares reversed course to fall 8% on Monday as focus shifted to the drug developer's ability to mass produce its oral obesity ...

(“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that new clinical data from ...

Viking Therapeutics. "Viking Therapeutics Reports New Data from VK2735 Obesity Program at ObesityWeek® 2024." Deutsche Bank. "VK2735 Shows Competitive Profile - Manuf. / Scaling will not be easy." ...

(RTTNews) - Shares of Viking Therapeutics ... the company reported positive new clinical data from its VK2735 obesity program. The company noted that higher doses of its oral tablet formulation ...